ImmuCell Corporation Amortization of Intangible Assets
ImmuCell Corporation (ICCC) reported Amortization of Intangible Assets of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-08-13
- ImmuCell Corporation amortization of intangible assets for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- ImmuCell Corporation amortization of intangible assets for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- ImmuCell Corporation amortization of intangible assets for the quarter ending 2025-12-31 was $4.78K, a 0.00% change year-over-year.
- ImmuCell Corporation amortization of intangible assets for the quarter ending 2025-09-30 was $4.78K, a 0.00% change year-over-year.
- ImmuCell Corporation amortization of intangible assets for fiscal 2025 was $19.10K, a 0.00% change from fiscal 2024.
- ImmuCell Corporation amortization of intangible assets for fiscal 2024 was $19.10K, a 0.00% change from fiscal 2023.
- ImmuCell Corporation amortization of intangible assets for fiscal 2023 was $19.10K, a 0.00% change from fiscal 2022.
- ImmuCell Corporation amortization of intangible assets for fiscal 2022 was $19.10K, a 0.00% change from fiscal 2021.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $0.00 10-Q · filed 2026-08-13 | $4.78K derived: sum of 3 quarters · filed 2026-08-13 | $9.55K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-14 | $4.78K derived: sum of 2 quarters · filed 2026-05-14 | $9.55K derived: sum of 3 quarters · filed 2026-05-14 | $14.33K derived: sum of 4 quarters · filed 2026-05-14 |
| 2025-12-31 | $4.78K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $9.55K derived: sum of 2 quarters · filed 2026-03-30 | $14.33K derived: sum of 3 quarters · filed 2026-03-30 | $19.10K 10-K · filed 2026-03-30 |
| 2025-09-30 | $4.78K 10-Q · filed 2025-11-13 | $9.55K derived: sum of 2 quarters · filed 2025-11-13 | $14.33K 10-Q · filed 2025-11-13 | $19.10K derived: sum of 4 quarters · filed 2026-05-14 |
| 2025-06-30 | $4.78K 10-Q · filed 2025-08-14 | $9.55K 10-Q · filed 2026-08-13 | $14.33K derived: sum of 3 quarters · filed 2026-05-14 | $19.10K derived: sum of 4 quarters · filed 2026-05-14 |
| 2025-03-31 | $4.78K 10-Q · filed 2026-05-14 | $9.55K derived: sum of 2 quarters · filed 2026-05-14 | $14.33K derived: sum of 3 quarters · filed 2026-05-14 | $19.10K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $4.78K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $9.55K derived: sum of 2 quarters · filed 2026-03-30 | $14.33K derived: sum of 3 quarters · filed 2026-03-30 | $19.10K 10-K · filed 2026-03-30 |
| 2024-09-30 | $4.78K 10-Q · filed 2025-11-13 | $9.55K derived: sum of 2 quarters · filed 2025-11-13 | $14.33K 10-Q · filed 2025-11-13 | $19.10K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $4.78K 10-Q · filed 2025-08-14 | $9.55K 10-Q · filed 2025-08-14 | $14.33K derived: sum of 3 quarters · filed 2025-08-14 | $19.10K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $4.78K 10-Q · filed 2025-05-14 | $9.55K derived: sum of 2 quarters · filed 2025-05-14 | $14.33K derived: sum of 3 quarters · filed 2025-05-14 | $19.10K derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $4.78K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $9.55K derived: sum of 2 quarters · filed 2025-03-28 | $14.33K derived: sum of 3 quarters · filed 2025-03-28 | $19.10K 10-K · filed 2025-03-28 |
| 2023-09-30 | $4.78K 10-Q · filed 2024-11-13 | $9.55K derived: sum of 2 quarters · filed 2024-11-13 | $14.33K 10-Q · filed 2024-11-13 | $19.10K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $4.78K 10-Q · filed 2024-08-13 | $9.55K 10-Q · filed 2024-08-13 | $14.33K derived: sum of 3 quarters · filed 2024-08-13 | $19.10K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $4.78K 10-Q · filed 2024-05-14 | $9.55K derived: sum of 2 quarters · filed 2024-05-14 | $14.33K derived: sum of 3 quarters · filed 2024-05-14 | $19.10K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $4.78K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $9.55K derived: sum of 2 quarters · filed 2024-04-01 | $14.33K derived: sum of 3 quarters · filed 2024-04-01 | $19.10K 10-K · filed 2024-04-01 |
| 2022-09-30 | $4.78K 10-Q · filed 2023-11-13 | $9.55K derived: sum of 2 quarters · filed 2023-11-13 | $14.33K 10-Q · filed 2023-11-13 | $19.10K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $4.78K 10-Q · filed 2023-08-10 | $9.55K 10-Q · filed 2023-08-10 | $14.33K derived: sum of 3 quarters · filed 2023-08-10 | $19.10K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $4.78K 10-Q · filed 2023-05-11 | $9.55K derived: sum of 2 quarters · filed 2023-05-11 | $14.33K derived: sum of 3 quarters · filed 2023-05-11 | $19.10K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $4.78K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $9.55K derived: sum of 2 quarters · filed 2023-03-29 | $14.33K derived: sum of 3 quarters · filed 2023-03-29 | $19.10K 10-K · filed 2023-03-29 |
| 2021-09-30 | $4.78K 10-Q · filed 2022-11-21 | $9.55K derived: sum of 2 quarters · filed 2022-11-21 | $14.33K 10-Q · filed 2022-11-21 | $19.10K derived: sum of 4 quarters · filed 2022-11-21 |
| 2021-06-30 | $4.78K 10-Q/A · filed 2022-11-21 | $9.55K 10-Q/A · filed 2022-11-21 | $14.33K derived: sum of 3 quarters · filed 2022-11-21 | $19.10K derived: sum of 4 quarters · filed 2022-11-21 |
| 2021-03-31 | $4.78K 10-Q · filed 2022-05-12 | $9.55K derived: sum of 2 quarters · filed 2022-05-12 | $14.33K derived: sum of 3 quarters · filed 2022-05-12 | $19.10K derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $4.78K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $9.55K derived: sum of 2 quarters · filed 2022-03-30 | $14.33K derived: sum of 3 quarters · filed 2022-03-30 | $19.10K 10-K · filed 2022-03-30 |
| 2020-09-30 | $4.78K 10-Q · filed 2021-11-15 | $9.55K derived: sum of 2 quarters · filed 2021-11-15 | $14.33K 10-Q · filed 2021-11-15 | $19.10K derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $4.78K 10-Q · filed 2021-08-12 | $9.55K 10-Q · filed 2021-08-12 | $14.33K derived: sum of 3 quarters · filed 2021-08-12 | $19.10K derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $4.78K 10-Q · filed 2021-05-13 | $9.55K derived: sum of 2 quarters · filed 2021-05-13 | $14.33K derived: sum of 3 quarters · filed 2021-05-13 | $19.10K derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | $4.78K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $9.55K derived: sum of 2 quarters · filed 2021-03-30 | $14.33K derived: sum of 3 quarters · filed 2021-03-30 | $19.10K 10-K · filed 2021-03-30 |
| 2019-09-30 | $4.78K 10-Q · filed 2020-11-12 | $9.55K derived: sum of 2 quarters · filed 2020-11-12 | $14.33K 10-Q · filed 2020-11-12 | $19.10K derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | $4.78K 10-Q · filed 2020-08-12 | $9.55K 10-Q · filed 2019-08-12 | $14.33K derived: sum of 3 quarters · filed 2020-08-12 | $19.10K derived: sum of 4 quarters · filed 2020-08-12 |
| 2019-03-31 | $4.78K 10-Q · filed 2020-05-13 | $9.55K derived: sum of 2 quarters · filed 2020-05-13 | $14.33K derived: sum of 3 quarters · filed 2020-05-13 | $19.10K derived: sum of 4 quarters · filed 2020-05-13 |
| 2018-12-31 | $4.78K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $9.55K derived: sum of 2 quarters · filed 2020-03-27 | $14.33K derived: sum of 3 quarters · filed 2020-03-27 | $19.10K 10-K · filed 2020-03-27 |
| 2018-09-30 | $4.78K 10-Q · filed 2019-11-12 | $9.55K derived: sum of 2 quarters · filed 2019-11-12 | $14.33K 10-Q · filed 2019-11-12 | $19.10K derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | $4.78K 10-Q · filed 2019-08-12 | $9.55K 10-Q · filed 2019-08-12 | $14.33K derived: sum of 3 quarters · filed 2019-08-12 | $19.10K derived: sum of 4 quarters · filed 2019-08-12 |
| 2018-03-31 | $4.78K 10-Q · filed 2019-05-13 | $9.55K derived: sum of 2 quarters · filed 2019-05-13 | $14.33K derived: sum of 3 quarters · filed 2019-05-13 | $19.10K derived: sum of 4 quarters · filed 2019-05-13 |
| 2017-12-31 | $4.78K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | $9.55K derived: sum of 2 quarters · filed 2019-03-22 | $14.33K derived: sum of 3 quarters · filed 2019-03-22 | $19.10K 10-K · filed 2019-03-22 |
| 2017-09-30 | $4.78K 10-Q · filed 2018-11-13 | $9.55K derived: sum of 2 quarters · filed 2018-11-13 | $14.33K 10-Q · filed 2018-11-13 | $18.12K derived: sum of 4 quarters · filed 2018-11-13 |
| 2017-06-30 | $4.78K 10-Q · filed 2018-08-13 | $9.55K 10-Q · filed 2018-08-13 | $13.35K derived: sum of 3 quarters · filed 2018-08-13 | $13.21K derived: sum of 4 quarters · filed 2018-08-13 |
| 2017-03-31 | $4.78K 10-Q · filed 2018-05-14 | $8.57K derived: sum of 2 quarters · filed 2018-05-14 | $8.44K derived: sum of 3 quarters · filed 2018-05-14 | $14.57K derived: sum of 4 quarters · filed 2018-05-14 |
| 2016-12-31 | $3.79K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | $3.66K derived: sum of 2 quarters · filed 2018-03-29 | $9.80K derived: sum of 3 quarters · filed 2018-03-29 | $19.10K 10-K · filed 2018-03-29 |
| 2016-09-30 | -$133.00 10-Q · filed 2017-11-13 | $6.00K derived: sum of 2 quarters · filed 2017-11-13 | $15.31K 10-Q · filed 2017-11-13 | |
| 2016-06-30 | $6.13K 10-Q · filed 2017-08-14 | $15.44K 10-Q · filed 2017-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |